Pathogenetix, Inc.
Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food safety, and clinical diagnostics.
Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food safety, and clinical diagnostics.
Pathogenetix, Inc. is a biotechnology startup dedicated to revolutionizing pathogen detection across various industries. The company's slogan, "Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food safety, and clinical diagnostics," reflects their core mission. Founded in 1997, Pathogenetix has developed an automated system utilizing Genome Sequence Scanning Technology to swiftly identify harmful bacterial strains. Their innovative method, involving a single reagent set to produce genomic barcodes from bacterial DNA, enables the cost-effective identification of thousands of strains within three hours. The company's GSS platform is poised to address applications in genomics research, food and product safety testing, and clinical infectious disease diagnostics. Notably, their Series C investment of $10.00M on 30 October 2013 saw participation from prominent firms including Ascension Ventures, Excel Venture Management, and HealthCare Ventures. With plans for an initial commercial launch in the research market in 2012, Pathogenetix is positioned to make a significant impact in the field of pathogen detection and genome sequencing.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | $10.00M | 3 |
|
30 Oct 2013 |
| Series B | $7.50M | 4 |
|
01 Nov 2011 |
| Series B | $4.00M | 3 |
|
01 Aug 2011 |
| Venture Round | $1.51M | - | 13 Dec 2010 | |
| Debt Financing | $1.00M | - | 19 Jan 2010 |
No recent news or press coverage available for Pathogenetix, Inc..
We care about your data, and we'd love to use cookies make your experience better.
